Concurrent Program Coordinator, Altamonte Springs Campus; Site Coordinator, University of Central Florida, College of Nursing, Orlando, FL, USAUnited States
Also available as PDF (figures and tables appear in the PDF).
Current media broadcasts have been reporting about the rapidly spreading outbreaks of the Zika virus now identified in South and Central America, as well as Mexico, the Caribbean, Puerto Rico and now in the United States. Focal activity of the Aedes species mosquito that transmits the Zika virus to humans through its bite, has been reported in South Florida. Prior to 2007, Zika was not reported outside of Africa and Asia, but since it was discovered recently in Brazil in 2015, the virus has swiftly spread across several continents. Zika is transmitted to humans by an infected mosquito bite during a blood meal by the Aedes species. They are also responsible for the transmission of dengue fever and chikungunya viruses. Unlike other species of mosquitos, the Aedes mosquitos often hide indoors and in shaded areas and are aggressive daytime biters, thus making it very challenging to prevent the spread of infections.1 Transmission occurs perinatally, in utero, sexual contact, blood transfusions and bodily fluids. To date, transmission through breastfeeding has not been reported, but limited studies are available, therefore absolute conclusions about modes of transmission cannot be determined at this time.
Keywords: Transmission occurs perinatally, in utero, sexual contact, blood transfusions and bodily fluids
WOMEN’S HEALTH Open Journal http://dx.doi.org/10.17140/WHOJ-2-e006 Women Health Open J ISSN 2380-3940 The Zika Virus has Arrived in the United States Susan Ricci, ARNP, MSN, Med, CNE* Concurrent Program Coordinator, Altamonte Springs Campus; Site Coordinator, University of Central Florida, College of Nursing, Orlando, FL, USA *Corresponding author Susan Scoot Ricci, ARNP, MSN, Med, CNE Concurrent Program Coordinator Altamonte Springs Campus; Site Coordinator University of Central Florida College of Nursing Orlando, FL, USA Tel. (407) 404-6088 E-mail: Susan.Ricci@ucf.edu Article History Received: August 27th, 2016 Accepted: August 29th, 2016 Published: August 29th, 2016 Citation Ricci SS. The Zika virus has ar- rived in the United States. Women Health Open J. 2016; 2(1): e6-e7.
doi: 10.17140/WHOJ-2-e006 Copyright ©2016 Ricci SS. This is an open access article distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Volume 2 : Issue 1 Article Ref. #: 1000WHOJ2e006 Editorial Page e6 Current media broadcasts have been reporting about the rapidly spreading outbreaks of the Zika virus now identified in South and Central America, as well as Mexico, the Carib- bean, Puerto Rico and now in the United States. Focal activity of the Aedes species mosquito that transmits the Zika virus to humans through its bite, has been reported in South Florida. Prior to 2007, Zika was not reported outside of Africa and Asia, but since it was discovered recently in Brazil in 2015, the virus has swiftly spread across several continents.
Zika is transmitted to humans by an infected mosquito bite during a blood meal by the Aedes species. They are also responsible for the transmission of dengue fever and chikungu- nya viruses. Unlike other species of mosquitos, the Aedes mosquitos often hide indoors and in shaded areas and are aggressive daytime biters, thus making it very challenging to prevent the spread of infections.1 Transmission occurs perinatally, in utero, sexual contact, blood transfu- sions and bodily fluids. To date, transmission through breastfeeding has not been reported, but limited studies are available, therefore absolute conclusions about modes of transmission can- not be determined at this time.2 Only about 1 in 5 people infected with Zika virus are symptomatic. In people who do experience symptoms, they will occur between 3 and 12 days after being bitten by an infected mosquito and will last between 2 and 7 days. The most common symptoms are fever, maculo - papular rash, headache, arthralgia, non-purulent conjunctivitis, myalgia, retro-orbital pain and vomiting.3 Severe disease requiring hospitalization are uncommon. As in the case of other viral illnesses, once infected, individuals are protected from future infection. Much focus has been on women that contract the Zika virus while pregnant. The Zika virus has been linked to microcephaly in newborns born to those infected. Microcephaly is a neurologic condition in which the newborn’s head is smaller and the result of abnormal brain development in utero. In addition to microcephaly, there is some evidence that the Zika virus is also linked to miscarriage and stillbirth.4 Testing for Zika currently involves blood and urine specimens. Polymerase chain reac- tion (PCR) can be used to detect viral ribonucleic acid (RNA) in serum and urine during the first week of illness and in urine alone for samples collected 1 to 3 weeks after illness onset. Both Zika virus PCR and antibody testing are commercially available.
Healthcare professionals play a key role in disseminating information to the public and must remain up-to-date with Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) recommendations. Clinicians should be educated about the hall - mark signs and symptoms of Zika virus and advise their clients about precautions to take. Pregnant women should protect themselves from mosquitoes and avoid traveling to regions where Zika virus is present. In addition, men who travel to infected areas should use condoms to protect their sexual partners. The use of Environmental Protection Agency (EPA) registered insect repellant can help prevent mosquito bites in all people.
WOMEN’S HEALTH Open Journal http://dx.doi.org/10.17140/WHOJ-2-e006 Women Health Open J ISSN 2380-3940 Page e7 The CDC has released clinical guidelines for the evaluation, clinical manifestations, diagnosis, and treatment of the Zika virus for all professionals. As it currently stands, there is no vaccine or prophylactic treatment available, but the first vaccine is in the pipeline.2 Healthcare professionals should educate their clients on infection control, personal protection, and prevention against this illness. These simple precautions may help prevent people from contracting the virus as well as the potential birth defects that could result.